Natalie Hosea
Dr. Natalie A. Hosea currently leads the Takeda California research facility and the Department of Drug Metabolism & Pharmacokinetics (DMPK) at the San Diego-based site. Each day, Natalie strives to lead talented, diverse, and highly engaged teams focused on accelerating the innovation and delivery of transformative medicines to patients.
Natalie received her Ph.D. in Biochemistry and Pharmacology at the University of California, San Diego, and completed a research fellowship at Vanderbilt University in Nashville, TN. Thereafter, she joined Pfizer in 1999, where she worked until 2015. After 16 years at Pfizer, Natalie took a new position leading the DMPK function in Takeda San Diego. Since then, here team has grown to include the development DMPK team in Boston where she and her team continue to impact drug discovery and development of both small molecule and biological therapeutics in Neuroscience and GI disease areas from new target through registration and life cycle management. In June 2020, Natalie was appointed as the site head of the Takeda research facility located in San Diego, overseeing the Facilities, Environmental Health & Safety and Administration functions. Outside of Takeda, Natalie is an advocate of professional development, mentorship, and STEM outreach at all educational levels.